Healthcare Providers and Services
Company Overview of New York Blood Center, Inc.
New York Blood Center, Inc. operates as a community-based non-profit blood collection and distribution organization in the United States. It offers various blood products and services, such as whole blood components, autologous and directed donation, frozen blood and rare blood, aphaeresis, clinical aphaeresis services, leukaphaeresis, cell salvage, hematopoietic stem cells, and immunohematology and genomics laboratory services to hospitals in New York, New Jersey, Hudson Valley, Long Island, and parts of Connecticut and Pennsylvania. The company also provides transfusion products and medical services, including bone marrow services, medical consultation, professional education, hemophilia s...
310 East 67th Street
New York, NY 10021
Founded in 1964
Key Executives for New York Blood Center, Inc.
Chief Executive Officer, President and Trustee
Chief Financial Officer and Senior Vice President
Chief Operating Officer and Senior Vice President
Vice President, General Counsel and Secretary
Chief Medical Officer, Senior Vice President and Trustee
Compensation as of Fiscal Year 2015.
New York Blood Center, Inc. Key Developments
New York Blood Center Announces New Collaboration with the University of California, Davis to Manufacture Specialized Lines of Stem Cells
Aug 20 15
New York Blood Center (NYBC) announced a new collaboration with the University of California, Davis, Health System to manufacture specialized lines of stem cells as potential therapies for repair and regeneration of retina, kidney, lung and liver tissue, as well as for the treatment of neurodegenerative disorders such as Parkinson's, Alzheimer's and Huntington's disease. Under the two-year agreement, UC Davis will produce induced pluripotent stem cells (iPSCs) from homozygous units from New York Blood Center's umbilical cord blood bank. Cord blood units contain adult stem cells collected from umbilical cord blood donations after the birth and safe delivery of a baby. NYBC's rare collection of homozygous units presents a unique opportunity to make iPSC lines that will be capable of making any human tissue and being matched to a large number of people. This will allow for vast new opportunities for future clinical use.
New York Blood Center, Inc. Announces Executive appointments
Aug 4 14
New York Blood Center, Inc. announced that Mr. Schmidtlein and former CBC board member Stephen Wurtzler will join the company's board.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries